The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis
Abstract The SEPT9 gene methylation assay is the first FDA-approved blood assay for colorectal cancer (CRC) screening. Fecal immunochemical test (FIT), FIT-DNA test and CEA assay are also in vitro diagnostic (IVD) tests used in CRC screening. This meta-analysis aims to review the SEPT9 assay perform...
Saved in:
Main Authors: | Lele Song, Jia Jia, Xiumei Peng, Wenhua Xiao, Yuemin Li |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/85bc8435fe9c4196991cda2e5dc58d96 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Au-delà des frontières, sept sociologies du travail
by: Le Comité de Rédaction de la NRT
Published: (2021) -
MiR-30a-5p antisense oligonucleotide suppresses glioma cell growth by targeting SEPT7.
by: Zhifan Jia, et al.
Published: (2013) -
Microbial dysbiosis in colorectal cancer (CRC) patients.
by: Iradj Sobhani, et al.
Published: (2011) -
Usefulness of a mobile app to improve performance of specialists in responding correctly to CRC screening and surveillance clinical scenarios
by: Lisandro Pereyra, et al.
Published: (2021) -
Comparison of the tuberculin skin test and interferon gamma release assay for the screening of tuberculosis in adolescents in close contact with tuberculosis TB patients.
by: Seung-Eun Song, et al.
Published: (2014)